Marfan syndrome (MFS) is a multisystemic disease associated with mutations
in the fibrillin-1 gene. Most of the reported mutations are missense substi
tutions mainly affecting the epidermal growth factor (EGF)-like protein dom
ain structure and the calcium-binding (cb) site. The aim of our study was t
o investigate the correlation between fibrillin-1 frameshift mutations and
the clinical phenotype in patients affected by MFS. In 48 out of 66 Marfan
patients a pathogenetic mutation was found. We detected novel mutations cau
sing premature termination codon in exons 19, 37, 40 and 41 of four Italian
patients. The first mutation in exon 19 (cbEGF #8 domain) results in a cli
nical phenotype involving mainly the skeletal and cardiovascular systems. I
nterestingly, we noticed that, while mutations in exons 37 and 41 (eight cy
steine domains #4 and #5) are milder, the mutation in exon 40 (cbEGF #24 do
main) is more severe and causes major cardiovascular involvement with thora
cic and abdominal aortic aneurysms. It is noteworthy that the degree of the
severity in the phenotype of one of our patients and another from the lite
rature carrying a mutation in exon 41 could be explained with alterations i
n mRNA expression.